Ocugen

FDA Greenlights Ocugen’s Breakthrough Gene Therapy Trial, Offering New Hope for Stargardt Disease Patients

MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN) announced a significant milestone with the U.S. Food and Drug Administration (FDA), gaining alignment to advance its Phase 2/3 pivotal confirmatory trial of OCU410ST, …

FDA Greenlights Ocugen’s Breakthrough Gene Therapy Trial, Offering New Hope for Stargardt Disease Patients Read More
Pennsylvania Officials Launch National Problem Gambling Awareness Month

Pennsylvania Rallies to Tackle Gambling Addiction: Resources, Stories, and Hope for Recovery

HARRISBURG, PA — State leaders, including Department of Drug and Alcohol Programs (DDAP) Secretary Dr. Latika Davis-Jones, gathered alongside representatives from the Pennsylvania Lottery, the Pennsylvania Gaming Control Board (PGCB), …

Pennsylvania Rallies to Tackle Gambling Addiction: Resources, Stories, and Hope for Recovery Read More


Addiction

Philadelphia’s Silent Crisis: The Alarming Rise of ‘Tranq’ Wounds and the Fight to Save Lives

PHILADELPHIA, PA — Surgeons and public health experts in Philadelphia are sounding the alarm over the severe medical challenges posed by xylazine-associated wounds, a crisis fueled by the increasing use of …

Philadelphia’s Silent Crisis: The Alarming Rise of ‘Tranq’ Wounds and the Fight to Save Lives Read More